Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verweij

Showing results (141-150 of 655) with videos related to

Pageof 66
Sort By:
Journal of Chromatography. B, Biomedical Sciences and Applications|January 12, 2000
Liquid chromatographic analysis and preliminary pharmacokinetics of methotrexate in cancer patients co-treated with docetaxelA Sparreboom, W J Loos, K Nooter, et al.
Vision Research|April 4, 2000
Sensitivity and dynamics of rod signals in H1 horizontal cells of the macaque monkey retinaJ Verweij, D M Dacey, B B Peterson, et al.
Pharmaceutisch Weekblad. Scientific Edition|October 18, 1991
Controlling cancer chemotherapy-induced emesis. An updateC Seynaeve, P H De Mulder, J Verweij, et al.
Expert Opinion on Therapeutic Targets|September 12, 2007
Trial design for cancer (cell)-specific anticancer therapiesRobbert J van Alphen, J Verweij, F A L M Eskens
European Journal of Nuclear Medicine|January 1, 1988
Indium 111 antimyosin for the detection of leiomyosarcoma and rhabdomyosarcomaP H Cox, J Verweij, M Pillay, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2000
Phase I trial with weekly EO9, a novel bioreductive alkylating indoloquinone, by the EORTC Early Clinical Study Group (ECSG)S Aamdal, B Lund, I Koier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2009
Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-upP G Casali, L Jost, S Sleijfer, et al.
Cancer|August 15, 1987
Prospective study on the dose relationship of mitomycin C-induced interstitial pneumonitisJ Verweij, T van Zanten, T Souren, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase II study of oral miltefosine in patients with squamous cell head and neck cancerJ Verweij, D Gandia, A S Planting, et al.
Anti-Cancer Drugs|March 23, 2001
Modulation of camptothecin analogs in the treatment of cancer: a reviewD F Kehrer, O Soepenberg, W J Loos, et al.
Pageof 66

Showing results (141-150 of 655) with videos related to

Sort By:
Pageof 66
Journal of Chromatography. B, Biomedical Sciences and Applications|January 12, 2000
Liquid chromatographic analysis and preliminary pharmacokinetics of methotrexate in cancer patients co-treated with docetaxelA Sparreboom, W J Loos, K Nooter, et al.
Vision Research|April 4, 2000
Sensitivity and dynamics of rod signals in H1 horizontal cells of the macaque monkey retinaJ Verweij, D M Dacey, B B Peterson, et al.
Pharmaceutisch Weekblad. Scientific Edition|October 18, 1991
Controlling cancer chemotherapy-induced emesis. An updateC Seynaeve, P H De Mulder, J Verweij, et al.
Expert Opinion on Therapeutic Targets|September 12, 2007
Trial design for cancer (cell)-specific anticancer therapiesRobbert J van Alphen, J Verweij, F A L M Eskens
European Journal of Nuclear Medicine|January 1, 1988
Indium 111 antimyosin for the detection of leiomyosarcoma and rhabdomyosarcomaP H Cox, J Verweij, M Pillay, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2000
Phase I trial with weekly EO9, a novel bioreductive alkylating indoloquinone, by the EORTC Early Clinical Study Group (ECSG)S Aamdal, B Lund, I Koier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2009
Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-upP G Casali, L Jost, S Sleijfer, et al.
Cancer|August 15, 1987
Prospective study on the dose relationship of mitomycin C-induced interstitial pneumonitisJ Verweij, T van Zanten, T Souren, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase II study of oral miltefosine in patients with squamous cell head and neck cancerJ Verweij, D Gandia, A S Planting, et al.
Anti-Cancer Drugs|March 23, 2001
Modulation of camptothecin analogs in the treatment of cancer: a reviewD F Kehrer, O Soepenberg, W J Loos, et al.
Pageof 66